International Conference on Oncology and Carcinogensis

This track focuses on the latest breakthroughs in oncology, including novel therapeutic strategies and innovative research methodologies. Participants will explore the implications of these advancements for patient care and treatment outcomes.

This session will delve into the molecular and cellular mechanisms underlying carcinogenesis, highlighting key signaling pathways and genetic factors. Discussions will include the role of environmental and lifestyle factors in cancer development.

This track will examine the design, implementation, and outcomes of clinical trials in oncology. Emphasis will be placed on emerging therapies and their potential to reshape cancer treatment paradigms.

Participants will investigate the role of immunotherapy in oncology, focusing on the latest developments in immune checkpoint inhibitors and CAR-T cell therapy. The session will address challenges and future directions in harnessing the immune system to combat cancer.

This track will explore the relationship between nutrition and cancer risk, emphasizing dietary interventions that may reduce incidence. Discussions will include the role of specific nutrients and dietary patterns in cancer prevention.

This session will focus on the unique challenges faced in pediatric oncology, including diagnosis, treatment, and long-term survivorship. Innovative approaches in research and clinical practice will be highlighted.

This track will cover the pharmacological aspects of drug development for cancer treatment, including pharmacokinetics and pharmacodynamics. Participants will discuss the challenges of drug resistance and strategies to overcome it.

This session will address public health initiatives aimed at cancer prevention and control, focusing on screening, education, and community engagement. The role of policy in shaping effective cancer control strategies will also be discussed.

This track will explore the integration of complementary and alternative medicine in oncology, examining evidence-based practices and patient outcomes. Discussions will focus on holistic approaches to cancer treatment and management.

Participants will investigate the impact of emerging technologies, such as artificial intelligence and genomics, on oncology research and clinical practice. The session will highlight how these technologies can enhance diagnosis and treatment.

This track will address the ethical challenges associated with oncology research, including informed consent, patient autonomy, and equitable access to treatment. Participants will engage in discussions on best practices for ethical conduct in clinical trials.